Carlsbad, United States
Arima Genomics, founded in 2015, is a promising player in the Biotechnology, Health Care, and Life Sciences sectors. Headquartered in the United States, the company is pioneering advancements in 3D genomics with its offering, which allows users to "Gain unparalleled access to the sequence + structure of any genome."
Specializing in analyzing the spatial and temporal changes in the 3D structure of genomes, Arima Genomics seeks to unlock new dimensions of gene regulation and cellular function, positioning itself as a transformative force in genomics research and applications.
The company secured a significant funding round with a $7.00M Series B investment on 15 March 2022. Notable investors include Tech Coast Angels, Cowin Venture, Berkeley Catalyst Fund, Genetron Health, Ladder Ventures, Hiaqua Investments, Vectr, and Agilent Technologies. This capital injection signals strong confidence in Arima’s growth potential and industry impact.
-logo.jpg "AGRF Ltd"){kind=logo}
Personal Genomics